Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes
MYOPRED
1 other identifier
observational
609
1 country
1
Brief Summary
Phacoemulsification with implantation of posterior chamber lenses represents the gold standard of care for patients needing lens surgery, but there is an increased risk of developing pseudophakic retinal detachment after surgery. Especially myopic patients have an even higher risk of pseudophakic retinal detachment compared to the general population. The aim of this multicenter study is to document the presence and/or post-operative development of posterior vitreous detachment (PVD) and to assess its influence on the incidence of retinal detachment (RD) in myopes in a time period of three and five years after lens surgery. 618 eyes of patients scheduled for regular lens surgery will be included, defined by an axial length of 25.0 mm or more. To examine the vitreous status, all patients will receive a comprehensive eye examination pre-operatively, including funduscopy with assessment of a Weiss ring and optical coherence tomography (OCT). Patients will be divided into two groups, group A with pre-operative complete PVD and group B with no/partial PVD. Group A will be invited for one follow-up visit (two months post-operatively) followed up by telephone interviews at one, two, three and five years after surgery to determine occurrence of pseudophakic retinal detachment. Group B will be invited for follow-up examinations at two months, six months and one year after surgery to document occurrence of PVD (if a PVD is present at one of the follow-ups, no more visits are necessary). Two, three and five years after surgery, all patients from group B will be interviewed by telephone, as in group A, to document the occurrence of pseudophakic retinal detachment. In the recent literature the association between the occurrence of PVD pre-/post-operative and RD after lens surgery is well documented but not described for myopic patients. The results of this multicenter study should help to tackle the problem of RD prediction in myopic patients depending on their pre-operative vitreous status, especially in the setting of refractive lens exchange.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2017
CompletedStudy Start
First participant enrolled
April 27, 2017
CompletedFirst Posted
Study publicly available on registry
May 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2025
CompletedMarch 13, 2026
March 1, 2026
7.5 years
April 19, 2017
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
PVD status
Number of patients with preoperative and/or post-operatively developed posterior vitreous detachment (PVD)
1 year
Incidence of RD
Influence of PVD on the incidence of retinal detachment (RD) in myopes after lens surgery.
5 years
Interventions
Eligibility Criteria
Study population: target 618. The participants will be selected by the clinical investigators at several ophthalmological centres in Austria, Belgium, Spain, Norway and the Netherlands. As the study population is already scheduled for cataract surgery / refractive lens exchange, recruitment will be performed directly in these centres at the pre-assessment visits. At this visit, optical biometry is performed and patients with suitable axial eye lengths will be screened. If all inclusion and no exclusion criteria are met the patients will be asked to participate in the trial.
You may qualify if:
- Minimum 21 years of age
- Patients scheduled for lens surgery with an axial eye length of 25.0 mm or more
- Availability, willingness, sufficient cognitive awareness to comply with examination procedures
- Ability to sign informed consent
You may not qualify if:
- Patients with combined surgery (e.g. combined phacoemulsification and vitrectomy or trabeculectomy or DSAEK)
- Patients with previous intraocular surgery (except any kind of laser surgery e.g. retinopexy, refractive laser surgery)
- Patients with recurrent severe anterior or posterior segment inflammation or uveitis of unknown aetiology, or any disease producing an inflammatory reaction in the eye
- Any ophthalmological pathology with the potential to compromise the measurements (e.g. mature/very dense cataract, fixation difficulties)
- Penetrating ocular trauma
- Previous history of retinal detachment
- Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
- Patients participating in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna Institute for Research in Ocular Surgery
Vienna, Vienna, 1140, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oliver Findl, Prof. Dr.
Vienna Institute for Research in Ocular Surgery
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator, Sponsor
Study Record Dates
First Submitted
April 19, 2017
First Posted
May 15, 2017
Study Start
April 27, 2017
Primary Completion
October 30, 2024
Study Completion
September 14, 2025
Last Updated
March 13, 2026
Record last verified: 2026-03